Advancing Clinical Research and Clinical Trial Standards in Southern Africa
February 12, 2020
SAHPRA CEO: Dr Boitumelo Semete-Makokotlela
One of the critical priorities of SAHPRA, since its launch, has been the clearance of its backlog of new medicine registration and variation applications and to prevent the development of backlog in the Business as Usual (BAU) stream.
This document provides an overview...